Rubato

Rubato connects clinical research with real-world skilled nursing deployment, offering biometrically personalized music-based intervention.

Health Tech & Life Sciences
Active
Pre-Seed Israel
Last updated 2026-09-03
Total raised
—
Last: Undisclosed Round 2022-03
Stage
Pre-Seed
Founded
—
Headcount
15
HQ
Israel
Sector
Health Tech & Life Sciences

About

Rubato is developing a technology that matches music to the listener's physiological and psychological state. The company utilizes algorithms and data based on machine learning, biometrics, and musical attributes. Its mission is to recommend music that scientifically helps people manage their stress, anxiety, and sleep quality by turning enjoyable music listening experiences into scientific biofeedback treatment. Rubato's technology analyzes individual cardiac and breathing rhythms and selects music based on key attributes such as tempo, key, scale, and structure. It then curates and delivers a personalized playlist that affects and optimizes the pertinent biomarkers, boosting music's scientifically proven benefits in order to help people improve their health and overall wellbeing. The company uses deep neural networks to identify and cluster different musical attributes, as well as heart-rate-variability vectors in large scale to quantify the music's effect. Based on a proprietary analysis method and algorithms, Rubato determines a scientific match between music and biomarkers, and generates insights for personal musical recommendations. It also provides a bio-hacking dashboard to track the music's effect on the body.

Offices

Israel · HQ / main office
Show all offices (1 more)
  • Los Angeles, United States

Q&A

What is Rubato's core business?
Rubato is developing AI-based music therapy technology that matches music to a listener's physiological and psychological state to help manage stress, anxiety, and sleep quality.
When was Rubato founded?
Rubato was founded in March 2020.
What is Rubato's current funding stage?
Rubato is currently in the Pre-Seed funding stage.
Which investors participated in Rubato's last funding round?
In March 2022, 97212 Ventures participated in Rubato's funding round.
Where is Rubato's headquarters located?
Rubato's headquarters is located in the Tel Aviv District, Israel.
Who are the co-founders of Rubato?
The co-founders of Rubato are Amit Sternberg (Co-founder and CEO) and Noam Guy (Co-founder and CTO).
What technologies does Rubato utilize?
Rubato utilizes Artificial Intelligence, Deep Learning, Machine Learning, Sensing, Motion, Platforms & Interfaces, and Software.

Team · 7

Amit Sternberg
Founder · Co-Founder & CEO
Noam Guy
Founder · Co-Founder & Software Architect
Mike Tully
VP Sales & Clinical Success, PT, DPT, OCS
INDRE VISKONTAS, PH.D.
Cognitive Neuroscience, Clinical Advisory Board
KIMBERLY LOCKWOOD, PH.D.
Physiological Measurement, Clinical Advisory Board
Claudius Conrad, MD, PhD, PhD, FACS, FSSO
Phyllis M. Wise Professor of Medicine and Innovation, Associate Dean for Research & Innovation, Carle Illinois College of Medicine, University of Illinois Urbana Champaign. Surgical Oncology, Carle Cancer Center. Professor, Carle Illinois College of Medicine and The Grainger College of Engineering. Affiliate, National Center for Supercomputing Applications. Director, Translational Research, Cancer Center at Illinois, Clinical Advisory Board
FRANK AHMANN
Healthcare Consultancy, CEO of XM Therapeutics, Clinical Advisory Board

Sectors & technology

Primary sector
Health Tech & Life Sciences
Technologies
Target customers
Business model
SaaS

Highlights

Verified

Tags

insurance-companieshealthcare-providersbiomarkersmusicbiometricsvital-signsmental-healthwell-beingemotions-analyticsdigital-therapeuticsmachine-learningartificial-intelligencepersonalizationdigital-healthcaredeep-neural-networksrecommendationswellness
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)